Discover
CGEM
Cullinan Therapeutics, Inc.
18.06
1 x 16.50
1 x 19.97
bid
ask
+
0.00
0.00%
1 @ 08:55 AM
17.97 -0.09 (0.50%)
| Ytd | 74.49% | |
| 1y | 140.16% |
day range
5.68
52 week range
19.43
| Open | Prev Close | 18.06 | Low | High | Mkt Cap | 1.11B | |||
| Vol | 0.00 | Avg Vol | 1.06M | EPS | -3.36 | P/E | -5.37 | Forward P/E | 6.74 |
| Beta | -0.01 | Short Ratio | 7.24 | Inst. Own | 107.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 15.99 | 200-d Avg | 12.62 | 1yr Est | 31.55 |
| Income Statement | |||
| Operating Expenses | 53.70M | ||
| Research and Development Expense | 42.12M | ||
| Selling, General and Administrative Expense | 11.57M | ||
| Operating Income | -53.70M | ||
| Net Income | -49.66M | ||
| Net Income Common Stock | -49.66M | ||
| Net Income Common Stock (USD) | -49.66M | ||
| Consolidated Income | -49.66M | ||
| Earnings per Basic Share | -0.75 | ||
| Earnings per Basic Share (USD) | -0.75 | ||
| Earnings per Diluted Share | -0.75 | ||
| Earning Before Interest & Taxes (EBIT) | -49.66M | ||
| Earning Before Interest & Taxes (USD) | -49.66M | ||
| Preferred Dividends Income Statement Impact | 562.52K | ||
| Weighted Average Shares | 60.46M | ||
| Weighted Average Shares Diluted | 60.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 75.08M | ||
| Cash and Equivalents (USD) | 75.08M | ||
| Investments | 315.31M | ||
| Investments Current | 276.80M | ||
| Investments Non-Current | 38.50M | ||
| Current Assets | 361.41M | ||
| Property, Plant & Equipment Net | 2.78M | ||
| Total Assets | 402.98M | ||
| Debt Current | 725.00K | ||
| Total Debt | 2.38M | ||
| Current Liabilities | 35.15M | ||
| Debt Non-Current | 1.66M | ||
| Total Liabilities | 36.81M | ||
| Accumulated Retained Earnings (Deficit) | -637.78M | ||
| Accumulated Other Comprehensive Income | 127.00K | ||
| Shareholders Equity | 366.17M | ||
| Shareholders Equity (USD) | 366.17M | ||
| Assets Non-Current | 41.58M | ||
| Total Debt (USD) | 2.38M | ||
| Liabilities Non-Current | 1.66M | ||
| Trade and Non-Trade Payables | 2.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 79.00K | ||
| Net Cash Flow from Financing | 380.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.25M | ||
| Issuance (Purchase) of Equity Shares | 380.00K | ||
| Net Cash Flow from Investing | 32.41M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 32.41M | ||
| Net Cash Flow from Operations | -46.04M | ||
| Share Based Compensation | 7.62M | ||